Strategic Research Program
Since our launch in 2006, our organization has experienced rapid growth. So far, 49 research consortia have been formed, combining 28 universities, their affiliated medical centers and knowledge institutes and 45 industrial partners including global pharmaceutical companies and small and medium-sized enterprises (SMEs). These 49 consortia form the core of TI Pharma’s Strategic Research Program: high quality science, addressing serious diseases confronting the modern world.
